EyePoint Pharmaceuticals, Inc. logo EYPT - EyePoint Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 16
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $37.50 DETAILS
HIGH: $39.00
LOW: $36.00
MEDIAN: $37.50
CONSENSUS: $37.50
UPSIDE: 190.02%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002
Revenue
Revenue 31.4 43.3 46.0 41.4 36.9 34.4 20.4 3.0 7.5 1.6 26.6 3.5 2.1 3.5 5.0 23.1 12.2 3.5 2.2 1.5 0.6 0.3 0.1 0.5
Cost of Revenue 2.1 3.7 4.6 8.3 8.2 5.8 2.7 18.5 0 0.8 14.4 0.1 9.6 7.0 7.0 0 0 0 0 0 0 0 0 0
Gross Profit 29.3 39.6 41.4 33.1 28.8 28.6 17.7 (15.5) 7.5 0.8 12.2 3.4 (7.4) (3.5) (2.1) 23.1 12.2 3.5 2.2 1.5 0.6 0.3 0.1 0.5
Operating Expenses
R&D Expenses 221.0 132.9 64.7 49.6 28.5 17.4 15.4 16.2 14.9 14.4 12.1 9.6 7.0 7.0 6.9 7.0 8.0 14.4 20.0 11.7 6.3 4.9 3.1 1.8
SG&A Expenses 51.7 52.5 51.8 60.3 53.1 46.0 47.7 13.1 11.2 9.0 8.1 7.5 7.2 6.9 8.1 7.0 8.8 14.0 13.0 15.9 3.8 1.6 0.6 0
Other Expenses 0 0 0 22.7 2.5 2.5 2.5 14.8 0 14.0 0.0 0 6.2 19.8 3.3 0 0 0 4.8 1.6 0.8 0.0 0.0 0
Operating Expenses 272.7 185.4 116.5 132.7 84.0 65.9 65.5 29.2 26.1 23.4 20.1 17.0 14.2 13.9 15.0 14.0 16.8 28.4 37.8 29.1 10.9 6.5 3.7 1.8
Operating Income
Operating Income (243.4) (145.9) (75.1) (99.6) (55.3) (37.3) (47.9) (26.3) (18.6) (21.8) 6.4 (13.5) (12.0) (25.2) (10.0) 9.1 (4.6) (24.9) (35.5) (27.7) (10.3) (6.2) (3.6) (1.8)
Interest Expense (0.0) 0.0 1.2 3.2 5.5 7.3 6.2 0.7 0.7 0 0 0.0 0.0 0 0.0 0.0 0 0.5 1.9 3.4 3.4 0.0 0.0 0
Interest Income 11.8 15.1 6.9 2.1 0.3 0.1 1.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.3 0.3 0 0 0 0
Profitability
EBITDA (243.4) (129.2) (69.0) (96.6) (50.1) (35.5) (48.0) (37.0) (18.6) (17.7) (20.9) 7.3 (12.7) (11.0) (22.8) (5.5) 9.1 (0.0) (75.6) (22.0) (19.0) (9.4) (6.0) (3.4)
EBIT (243.4) (130.8) (69.5) (99.1) (52.9) (38.1) (50.6) (39.0) (52.5) (18.5) (21.7) 6.4 (13.5) (12.0) (25.0) (8.8) 9.1 (3.5) (75.6) (35.5) (27.7) (14.5) (6.2) (3.6)
Income Before Tax (231.7) (130.8) (70.7) (102.3) (58.4) (45.4) (56.8) (53.2) (18.5) (21.7) 6.4 (13.5) (12.0) (25.0) (8.8) 8.8 (3.5) (76.2) (127.2) (28.0) (11.5) (5.2) (3.6) (2.3)
Income Tax Expense 0.3 0.1 0.1 0 0 0 0 (25.6) (0.8) (0.2) 0.1 (0.1) (0.1) (0.2) (0.2) 0.0 (1.0) (0.5) (23.5) (7.1) (0.3) (2.7) (1.7) (1.8)
Net Income (232.0) (130.9) (70.8) (102.3) (58.4) (45.4) (56.8) (53.2) (18.5) (21.5) 6.3 (13.4) (11.9) (24.8) (8.6) 8.8 (2.5) (75.7) (103.7) (20.9) (11.2) (2.6) (1.9) (2.3)
Per Share Data
EPS (Basic) -3.17 -2.32 -1.82 -2.74 -2.03 -3.54 -6.04 -11.50 -5.23 -6.81 2.16 -4.87 -5.16 -11.95 -4.43 4.76 -1.37 -41.65 -93.93 -27.81 -5.73 -1.68 -1.35 -0.05
EPS (Diluted) -3.17 -2.32 -1.82 -2.74 -2.03 -3.54 -6.04 -11.50 -5.23 -6.81 2.08 -4.87 -5.16 -11.95 -4.43 4.63 -1.37 -41.65 -93.93 -27.81 -5.73 -2.08 -1.35 -0.05
Shares Outstanding 73.3 56.3 38.9 37.3 28.8 12.8 10.4 4.6 3.5 3.2 2.9 2.7 2.3 2.1 1.9 1.8 1.8 1.8 1.1 0.8 2.0 1.5 1.4 41.1
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2009 2008 2004 2003 2001
Current Assets
Cash & Cash Equivalents 101.8 99.7 281.3 95.6 178.6 44.9 22.2 38.8 16.9 15.3 6.9 9.8 21.8 0.8 1.6
Short-Term Investments 204.3 271.2 49.8 48.9 33.0 0 0 0 0 13.7 0 0 0 0 0
Net Receivables 0.7 0.6 0.8 15.5 18.4 9.5 11.4 0.4 0.4 0.3 1.1 0.9 0.2 0.1 0.1
Inventory 1.8 2.3 3.9 2.9 3.6 5.3 2.1 (0.4) (0.3) (0.5) 0 0 0 0 0
Other Current Assets 20.1 1.4 1.0 0.8 0.5 0 0 1.1 0 0 0 0 0 0 0.0
Total Current Assets 328.7 383.3 344.8 172.8 237.7 63.1 41.7 39.9 17.7 30.0 8.1 10.9 22.0 0.9 1.7
Non-Current Assets
Property, Plant & Equipment 20.2 29.2 10.2 7.4 2.7 3.2 3.4 0.3 0.3 0.3 0.1 0.4 0.5 0.3 0.4
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 17.7 0 0
Intangible Assets 0 0 0 0 22.7 25.2 27.7 31.4 0.4 1.1 28.8 27.9 39.0 3.6 2.6
Long-Term Investments 0 0 0 0 0 0 0 0.1 0 0.1 0 0 0 0 0
Other Non-Current Assets 15.1 6.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.3 0.1 0.1 0.0 0.0 0
Total Non-Current Assets 35.3 35.2 10.4 7.5 25.6 28.6 31.3 31.8 0.9 1.7 29.0 28.3 6.0 3.9 3.0
Total Assets 364.0 418.5 355.2 180.4 263.4 91.7 73.0 71.7 18.7 31.6 37.1 39.2 28.1 4.8 4.7
Current Liabilities
Account Payables 34.9 11.7 6.5 5.9 7.4 4.8 4.2 2.6 2.9 1.0 0.4 0.4 1.5 0.8 0
Short-Term Debt 0 0 0 10.5 0 0 0 0 0 0 0 0 0 0 0
Deferred Revenue 0 17.8 38.6 1.2 1.1 0.9 0.0 0.0 0.1 0.1 5.9 11.0 0 0 0
Other Current Liabilities 2.1 13.3 13.3 9.5 7.3 5.7 3.3 15 (14.6) 2.6 1.3 0.4 0.0 (0.7) 0.1
Total Current Liabilities 37.0 49.0 63.3 34.5 23.7 14.9 11.5 21.7 5.3 5.1 8.7 13.1 1.3 0.6 0.1
Non-Current Liabilities
Long-Term Debt 0 0 0 29.3 36.6 38.0 47.2 17.3 17.3 0 0 0 0 0 0.1
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0.2 0.3 0 0 0
Other Non-Current Liabilities 0.1 0.2 0 0.6 2.4 2.4 3 21.0 (17.3) 0.1 0 0 0 0 (0.1)
Total Non-Current Liabilities 20.9 32.9 25.6 49.5 55.3 58.3 53.1 38.3 0.1 5.6 4.8 4.3 0.8 0.4 0
Total Liabilities 57.9 82.0 88.9 84.0 79.0 73.2 64.6 60.0 5.3 10.7 13.6 17.4 1.3 0.6 0.1
Stockholders' Equity
Common Stock 1,410.1 0.1 0.0 0.0 0.0 0.0 0.0 374.8 323.3 312.2 0.0 0.0 34.7 10.5 6.2
Retained Earnings (1,105.0) (873.0) (742.1) (671.4) (569.1) (510.7) (465.3) (364.0) (310.8) (292.2) (227.0) (225.9) (9.2) (6.4) (2.3)
Accumulated Other Comprehensive Income 1.0 1.0 0.9 0.8 0.8 0.8 0.8 0.8 0.8 0.9 2.1 (0.3) 0.1 0.0 0
Total Stockholders' Equity 306.1 336.5 266.3 96.4 184.4 18.5 8.3 11.7 13.3 20.9 23.5 21.8 25.6 4.1 4.6
Total Liabilities & Equity 364.0 418.5 355.2 180.4 263.4 91.7 73.0 71.7 18.7 31.6 37.1 39.2 28.1 4.8 4.7
Debt Metrics
Total Debt 20.8 21.9 4.9 46.3 39.2 41.0 50.6 17.3 17.3 0 0 0 0 0 0.1
Net Debt (81.0) (77.8) (276.4) (49.3) (139.4) (3.9) 28.4 (21.5) 0.4 (15.3) (6.9) (9.8) (21.8) (0.8) (1.5)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2005 2004 2003
Operating Activities
Net Income (232.0) (130.9) (70.8) (102.3) (58.4) (45.4) (56.8) (53.2) (18.5) (21.5) (11.5) (5.2) (3.6)
Depreciation & Amortization 2.3 1.5 0.5 2.4 2.8 2.6 2.6 1.1 0.8 0.9 1.2 0.2 0.2
Stock-Based Compensation 27.9 36.7 12.1 14.2 7.4 5.5 4.6 4.0 2.7 2.5 0 0 0
Change in Working Capital (33.8) (27.8) 58.9 (3.0) (1.7) 20.1 (12.5) 0.9 0.3 2.1 (0.3) 0.6 0.3
Other Non-Cash Items (4.8) (6.0) 1.2 23.6 0.6 1.7 1.6 0.2 (5.6) 0.1 1.2 (1.0) 0.1
Operating Cash Flow (240.1) (126.2) 1.9 (65.0) (50.1) (14.4) (56.7) (21.9) (20.5) (16.3) (9.3) (5.4) (3.1)
Investing Activities
Capital Expenditure (3.3) (4.1) (3.5) (2.1) (0.2) (0.4) (0.2) (0.1) (0.1) (0.1) (2.6) (0.4) (0.0)
Acquisitions 0.2 0 (0.2) (0.6) 0 0 0 (16.8) (16.8) 0.0 (4,033.1) 0 (0.4)
Purchases of Investments (252.0) (398.3) (55.1) (139.1) (33.0) 0 0 0 (5.1) (17.5) 0 0 0
Sales/Maturities of Investments 318.9 177.0 55.3 124 0 0 0 0 18.7 13.2 0 0 0
Other Investing Activities 4.8 6.0 0.2 0.6 0 0 0 0 0.0 13.7 (3.5) 0 0.4
Investing Cash Flow 68.6 (219.4) (3.3) (17.3) (33.1) (0.4) (0.2) (16.9) 13.6 (4.5) (6.1) (0.4) (0.0)
Financing Activities
Net Debt Issuance (0.1) (0.1) (40.5) 2.1 (0.1) (11.8) 30 20 20 0 14.4 0 0
Stock Repurchased 0 0 0 (0.3) 0 0 0 (0.2) 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (1.4) 0.8 1.4 (3.2) 0.2 (0.6) 4.0 (20.2) (0.8) 0.1 (0.3) (0.0) 0.3
Financing Cash Flow 173.6 164.0 187.1 (0.7) 216.9 37.5 33.9 60.7 8.5 17.0 2.8 25.7 0.6
Cash Position
Net Change in Cash 2.1 (181.6) 185.6 (83.0) 133.7 22.7 (23.0) 21.9 1.6 (3.8) (14.0) 21.0 (2.6)
Cash at Beginning 99.9 281.4 95.6 178.7 45.1 22.4 45.4 17.0 15.3 19.1 23.8 0.8 3.4
Cash at End 102.0 99.9 281.3 95.8 178.7 45.1 22.4 38.9 16.9 15.3 9.8 21.8 0.8
Free Cash Flow (243.4) (130.3) (1.6) (67.2) (50.3) (14.8) (56.9) (22.0) (20.6) (16.4) (11.9) (5.8) (3.1)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002
Income Statement
Revenue 31.4 43.3 46.0 41.4 36.9 34.4 20.4 3.0 7.5 1.6 26.6 3.5 2.1 3.5 5.0 23.1 12.2 3.5 2.2 1.5 0.6 0.3 0.1 0.5
Gross Profit 29.3 39.6 41.4 33.1 28.8 28.6 17.7 (15.5) 7.5 0.8 12.2 3.4 (7.4) (3.5) (2.1) 23.1 12.2 3.5 2.2 1.5 0.6 0.3 0.1 0.5
Operating Income (243.4) (145.9) (75.1) (99.6) (55.3) (37.3) (47.9) (26.3) (18.6) (21.8) 6.4 (13.5) (12.0) (25.2) (10.0) 9.1 (4.6) (24.9) (35.5) (27.7) (10.3) (6.2) (3.6) (1.8)
Net Income (232.0) (130.9) (70.8) (102.3) (58.4) (45.4) (56.8) (53.2) (18.5) (21.5) 6.3 (13.4) (11.9) (24.8) (8.6) 8.8 (2.5) (75.7) (103.7) (20.9) (11.2) (2.6) (1.9) (2.3)
EPS (Diluted) -3.17 -2.32 -1.82 -2.74 -2.03 -3.54 -6.04 -11.50 -5.23 -6.81 2.08 -4.87 -5.16 -11.95 -4.43 4.63 -1.37 -41.65 -93.93 -27.81 -5.73 -2.08 -1.35 -0.05
Balance Sheet
Cash & Equivalents 101.8 99.7 281.3 95.6 178.6 44.9 22.2 38.8 16.9 15.3 6.9 9.8 21.8 0.8 1.6
Total Assets 364.0 418.5 355.2 180.4 263.4 91.7 73.0 71.7 18.7 31.6 37.1 39.2 28.1 4.8 4.7
Total Debt 20.8 21.9 4.9 46.3 39.2 41.0 50.6 17.3 17.3 0 0 0 0 0 0.1
Stockholders' Equity 306.1 336.5 266.3 96.4 184.4 18.5 8.3 11.7 13.3 20.9 23.5 21.8 25.6 4.1 4.6
Cash Flow
Operating Cash Flow (240.1) (126.2) 1.9 (65.0) (50.1) (14.4) (56.7) (21.9) (20.5) (16.3) (9.3) (5.4) (3.1)
Capital Expenditure (3.3) (4.1) (3.5) (2.1) (0.2) (0.4) (0.2) (0.1) (0.1) (0.1) (2.6) (0.4) (0.0)
Free Cash Flow (243.4) (130.3) (1.6) (67.2) (50.3) (14.8) (56.9) (22.0) (20.6) (16.4) (11.9) (5.8) (3.1)